Literature DB >> 8018929

Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion.

J O Bordin1, L Bardossy, M A Blajchman.   

Abstract

We had reported previously (Blood 81:1880, 1993) that allogeneic blood transfusions (ABT) administered before the infusion of tumor cells in both inbred and outbred experimental animals promote tumor growth and that this effect can be ameliorated by leukodepletion. To better reproduce the human situation, we evaluated, in this present study, the effect of ABT in animals with established tumors using enumeration of pulmonary metastatic nodules as the end point. The role of allogeneic blood component transfusions in promoting tumor growth and the relative efficacy of prestorage versus poststorage leukodepletion of the ABT in preventing tumor growth enhancement were also evaluated. In an inbred murine animal model, C57Bl/6J mice were administered nonleukodepleted allogeneic (ABT), leukodepleted allogeneic (LD-ABT), or syngeneic (SBT) blood transfusions after the intravenous infusion of syngeneic methylcholanthrene-induced fibrosarcoma cells using two different protocols. A significant increase in the number of pulmonary nodules was observed in those mice that received ABT, in both protocols, compared to animals transfused with SBT or LD-ABT. Significantly higher numbers of pulmonary nodules were also seen in mice transfused with allogeneic buffy-coat leukocytes compared with mice that received either nonleukodepleted allogeneic plasma or LD-ABT. In an outbred animal (rabbit) model, recipient rabbits were administered either nonleukodepleted ABT, prestorage LD-ABT, poststorage LD-ABT, or SBT on days +4 and +9 after the infusion of syngeneic epithelial tumor cells. A significant increase in the number of pulmonary nodules was seen in rabbits that received nonleukodepleted ABT compared to animals transfused with SBT. Significantly lower numbers of pulmonary nodules were observed in rabbits that received prestorage LD-ABT compared to animals transfused with poststorage LD-ABT, but no significant difference was seen in rabbits that received poststorage LD-ABT compared with animals transfused with nonleukodepleted ABT. These studies show that ABT promote tumor growth of established animal tumors, that the ABT-induced tumor growth effect is related to the presence of donor allogeneic leukocytes, and that this effect can be ameliorated by prestorage leukodepletion. The present results also provide evidence for the lack of efficacy of poststorage leukodepletion in preventing ABT tumor growth promotion.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8018929

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  The immunocompromised patient and transfusion.

Authors:  K G Badami
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

2.  Blood storage duration and biochemical recurrence of cancer after radical prostatectomy.

Authors:  Juan P Cata; Eric A Klein; Gerald A Hoeltge; Jarrod E Dalton; Edward Mascha; Jerome O'Hara; Amanda Russell; Andrea Kurz; Shamgar Ben-Elihayhu; Daniel I Sessler
Journal:  Mayo Clin Proc       Date:  2011-02       Impact factor: 7.616

3.  Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy. Autologous transfusion on hepatectomy outcome.

Authors:  James O Park; Mithat Gonen; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; David Wuest; Leslie H Blumgart; William R Jarnagin
Journal:  J Gastrointest Surg       Date:  2007-07-31       Impact factor: 3.452

4.  Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma.

Authors:  E Clark; S Connor; M A Taylor; C L Hendry; K K Madhavan; O J Garden; R W Parks
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

5.  The plasma fraction of stored erythrocytes augments pancreatic cancer metastasis in male versus female mice.

Authors:  Peter K Moore; Douglas Benson; Marguerite Kehler; Ernest E Moore; Miguel Fragoso; Christopher C Silliman; Carlton C Barnett
Journal:  J Surg Res       Date:  2010-06-13       Impact factor: 2.192

Review 6.  A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.

Authors:  Y Beguin
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

7.  Stored red blood cell transfusion induces regulatory T cells.

Authors:  Joel M Baumgartner; Christopher C Silliman; Ernest E Moore; Anirban Banerjee; Martin D McCarter
Journal:  J Am Coll Surg       Date:  2008-10-10       Impact factor: 6.113

8.  Blood transfusion promotes cancer progression: a critical role for aged erythrocytes.

Authors:  Shir Atzil; Michal Arad; Ariella Glasner; Noa Abiri; Roi Avraham; Keren Greenfeld; Ella Rosenne; Benzion Beilin; Shamgar Ben-Eliyahu
Journal:  Anesthesiology       Date:  2008-12       Impact factor: 7.892

9.  Analysis of Plasma Products for Cellular Contaminants: Comparing Standard Preparation Methods.

Authors:  Richard R Rieske; Matthew E Kutcher; Jon P Audia; Kristen T Carter; Yann-Leei Lee; Yong B Tan; Mark N Gillespie; Gina C Capley; Danielle M Tatum; Alison A Smith; Juan C Duchesne; Jon D Simmons
Journal:  J Am Coll Surg       Date:  2020-04       Impact factor: 6.113

10.  Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer.

Authors:  Frederike C Ling; Arnulf H Hoelscher; Daniel Vallböhmer; Daniel Schmidt; Susanne Picker; Birgit S Gathof; Elfriede Bollschweiler; Paul M Schneider
Journal:  J Gastrointest Surg       Date:  2009-01-17       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.